The IPO Buzz: Seaport Therapeutics Prices Upsized IPO at $18 & Stock Gains 16.7 Percent
Seaport Therapeutics (SPTX), a Boston-based biotech developing drugs to treat major depression, increased its IPO’s size at pricing – to 14.16 million shares – up from 11.8 million in the prospectus – and priced its IPO at $18.00 – the top of its range – to raise $254.88 million on Thursday night, April 30, 2026. Shares […]
May 1, 2026 Read More